Eiger Mountains
Corporate Profile
Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development... More >>
Stock Quote
EIGR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$13.87
Change (%)0.00 (0.00%)
Volume0
Data as of 09/28/16 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
09/07/16Eiger Announces Completion of Dosing in Phase 2 LOWR HDV - 4 Study at Hannover Medical School
09/06/16Eiger BioPharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference on September 9th
09/01/16Eiger BioPharmaceuticals to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016
08/18/16Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
Upcoming EventsMore >>
DateTitle
09/30/16
Eiger BioPharmaceuticals at Eiger BioPharmaceuticals at Piper 28th Annual Healthcare Conference
11/11/16
Eiger BioPharmaceuticals at AASLD Boston
11/29/16
Eiger BioPharmaceuticals at Oppenheimer Life Sciences Summit
What's New
There are currently no items available.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Eiger BioPharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.